Merck Treatment Gets FDA Priority Review - InvestorsObserver

ADAG Stock  USD 2.05  0.04  1.99%   
Roughly 55% of Adagene's stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Adagene suggests that some traders are interested. The current market sentiment, together with Adagene's historical and current headlines, can help investors time the market. In addition, many technical investors use Adagene stock news signals to limit their universe of possible portfolio assets.
  
Merck Treatment Gets FDA Priority Review InvestorsObserver

Read at news.google.com
Google News at Macroaxis
  

Adagene Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Adagene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Adagene Fundamental Analysis

We analyze Adagene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adagene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adagene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Adagene is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Adagene Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adagene stock to make a market-neutral strategy. Peer analysis of Adagene could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics with similar companies.

Peers

Adagene Related Equities

MLYSMineralys Therapeutics,   4.31   
0%
39.0%
RZLTRezolute   3.78   
0%
34.0%
PMVPPmv Pharmaceuticals   0.67   
0%
6.0%
ACRVAcrivon Therapeutics,   0.30   
0%
2.0%
JANXJanux Therapeutics   0.14   
0%
1.0%
ANTXAN2 Therapeutics   0.79   
7.0%
0%
AVTEAerovate Therapeutics   1.17   
10.0%
0%
MOLNMolecular Partners   2.68   
24.0%
0%
ANABAnaptysBio   3.00   
27.0%
0%
ANEBAnebulo Pharmaceuticals   10.81   
100.0%
0%

Complementary Tools for Adagene Stock analysis

When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device